Display Accessibility Tools

Accessibility Tools


Highlight Links

Change Contrast

Increase Text Size

Increase Letter Spacing

Readability Bar

Dyslexia Friendly Font

Increase Cursor Size


Search and Filter
Hero image
November 26, 2021
In a partnership between MSU and Spectrum Health called the Cystic Fibrosis Translational Research program, a team of researchers including MSU biochemist Robert Quinn, is studying the effectiveness of a promising FDA approved treatment called Trikafta that is a combination of the drugs Elexacaftor, Tezacaftor and Ivacaftor. The new treatment is proving to be life-changing for people with cystic fibrosis. The research was published Nov. 24 in the Journal of Cystic Fibrosis.

Latest News

Share Your News

We love hearing about the hard earned accomplishments and achievements of the people of MSU College of Natural Science.  Please submit your news/announcement here to help NatSci share your story.